Literature DB >> 27641783

Quantification of coronary artery motion and internal risk volume from ECG gated radiotherapy planning scans.

Tejinder Kataria1, Shyam Singh Bisht1, Deepak Gupta1, Ashu Abhishek1, Trinanjan Basu1, Kushal Narang1, Shikha Goyal1, Pragya Shukla2, Manish Bansal3, Hardeep Grewal3, Kulbeer Ahlawat4, Susovan Banarjee1, Manoj Tayal1.   

Abstract

BACKGROUND: Radiotherapy for carcinoma of breast and thoracic structures involves inadvertent radiation to heart and coronary arteries (CA). Coronary artery stenosis in high radiation dose segments has been documented. Cardiac and respiratory motion induced displacement of CA and internal risk volume (IRV) margin remains inadequately quantified.
MATERIAL AND METHODS: Twenty cases of carcinoma breast, lung and lung metastasis were enrolled in this study. ECG gated intravenous contrast enhanced computed tomography (CECT) scans were performed in inspiratory breath hold (IBH) and expiratory breath hold (EBH). The images were segregated into inspiratory systole (IS), inspiratory diastole (ID), expiratory systole (ES) and expiratory diastole (ED) sets. Left anterior descending (LAD), limited segment of LAD close to chest wall (short LAD), right coronary artery (RCA), Left circumflex artery (LCX) and left ventricle (LV) were delineated in all four sets. Mean displacements in systole versus diastole and inspiration versus expiration were calculated in three co-ordinates [anterio-posterior (Z), left-right (X) and cranio-caudal (Y)].
RESULTS: Mean of displacement (mm) between systole and diastole (IS versus ID; and ES versus ED) in X, Y, Z co-ordinates were: LAD 3.0(±1.6), 2.8(±1.5), 3.6(±2.0); Short-LAD 3.0(±1.1), 0.8(±0.4), 2.4(±0.6); LV 2.4(±1.6), 1.7(±1), 5.0(±1.5); LCX 4.9(±1.6), 2.9(±1.3), 5.1(±1.9); RCA 6.6(±2.2), 3.6(±2.1), 5.9(±2.2). Mean displacement between inspiration and expiration (IS versus ES; and ID versus ED) in X, Y, Z axes were: LAD 3.3(±1.5), 8.0(±3.4), 3.8(±1.8); Short-LAD 2.7(±1), 12.2(±4.4), 3.3(±1.5); LV 2.9(±1.4), 9.8(±3.3), 4.7(±1.9); LCX 2.9(±.8), 9.7(±3.2), 6.2(±2.5); RCA 2.6(±1.3), 7.6(±2.5), 3.8(±1.7).
CONCLUSION: Radial (RM), cranio-caudal margin (CC) of 7mm, 4mm in breath-hold radiotherapy whereas RM, CC of 7mm, 13mm respectively in free breath radiotherapy will cover the range of motions of CA, LV and can be recommended as IRV for these structures.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery motion; ECG gated; IRV; Internal risk volume; Thoracic radiotherapy

Mesh:

Year:  2016        PMID: 27641783     DOI: 10.1016/j.radonc.2016.08.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Quantification of radiation dose reduction by reducing z-axis coverage in 320-detector coronary CT angiography.

Authors:  David J Murphy; Abhishek Keraliya; Nathan Himes; Ayaz Aghayev; Ron Blankstein; Michael L Steigner
Journal:  Br J Radiol       Date:  2017-06-14       Impact factor: 3.039

2.  Cardiac substructure segmentation with deep learning for improved cardiac sparing.

Authors:  Eric D Morris; Ahmed I Ghanem; Ming Dong; Milan V Pantelic; Eleanor M Walker; Carri K Glide-Hurst
Journal:  Med Phys       Date:  2019-12-29       Impact factor: 4.071

3.  The margin of internal risk volume on atrial septal and ventricular septal based on electrocardiograph gating 4DCT.

Authors:  Qian Li; Ying Tong; Guanzhong Gong; Yong Yin; Yaping Xu
Journal:  Ann Transl Med       Date:  2021-05

4.  Impact of deformable image registration on dose accumulation applied electrocardiograph-gated 4DCT in the heart and left ventricular myocardium during esophageal cancer radiotherapy.

Authors:  Ying Tong; Yong Yin; Pinjing Cheng; Guanzhong Gong
Journal:  Radiat Oncol       Date:  2018-08-10       Impact factor: 3.481

5.  Quantification of variation in dose-volume parameters for the heart, pericardium and left ventricular myocardium during thoracic tumor radiotherapy.

Authors:  Ying Tong; Yong Yin; Pinjing Cheng; Jie Lu; Tonghai Liu; Jinhu Chen; Guanzhong Gong
Journal:  J Radiat Res       Date:  2018-07-01       Impact factor: 2.724

6.  Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer.

Authors:  Lidia Guzhva; Stella Flampouri; Nancy P Mendenhall; Christopher G Morris; Bradford S Hoppe
Journal:  Adv Radiat Oncol       Date:  2019-03-29

Review 7.  Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum.

Authors:  Andrea Riccardo Filippi; Sofia Meregalli; Anna DI Russo; Mario Levis; Patrizia Ciammella; Michela Buglione; Andrea Emanuele Guerini; Giuseppina De Marco; Vitaliana De Sanctis; Stefano Vagge; Umberto Ricardi; Gabriele Simontacchi
Journal:  Radiat Oncol       Date:  2020-03-12       Impact factor: 3.481

8.  Electrocardiogram-Gated Computed Tomography with Coronary Angiography for Cardiac Substructure Delineation and Sparing in Patients with Mediastinal Lymphomas Treated with Radiation Therapy.

Authors:  Scott C Lester; Kekoa Taparra; Molly M Petersen; Ryan K Funk; Miran J Blanchard; Phillip M Young; Joerg Herrmann; Ashley E Hunzeker; Heather L Schultz; Cynthia McCollough; Alexandria M Tasson; Shuai Leng; James A Martenson; Amanda J Deisher; Thomas J Whitaker; Eric E Williamson; Nadia N Laack
Journal:  Pract Radiat Oncol       Date:  2019-11-26

9.  Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy.

Authors:  Ying Tong; Yong Yin; Jie Lu; Tonghai Liu; Jinhu Chen; Pinjing Cheng; Guanzhong Gong
Journal:  Onco Targets Ther       Date:  2018-01-24       Impact factor: 4.147

10.  Study on the Effect of 4D-CT Special Reconstruction Images for Evaluation of the Cardiac Structure Dose in Radiotherapy for Breast Cancer.

Authors:  Ming Su; Guanzhong Gong; Xiaoping Qiu; Ying Tong; Qian Li; Yong Yin
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.